Marc Cobo
Fortuna: 48 716 $ al 31/05/2026
Fortuna: 48 716 $ al 31/05/2026
Marc Cobo currently works at Bridgebio Oncology Therapeutics, Inc., as Vice President-Finance & Controller from 2025 and Bridgebio Oncology Therapeutics, Inc., as Chief Accounting Officer from 2026.
Mr. Cobo also formerly worked at Tricida, Inc., as Chief Accounting Officer & Senior VP-Finance in 2020 and SFJ Pharmaceuticals, Inc., as Chief Accounting Officer & Executive VP from 2021 to 2024.
Mr. Cobo received his undergraduate degree from Santa Clara University and undergraduate degree from Leavey School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,01 % | 21/04/2026 | 5.431 ( 0,01 % ) | 48 716 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Comptroller/Controller/Auditor | 01/03/2024 |
| TRICIDA, INC. | Comptroller/Controller/Auditor | 04/12/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Tricida, Inc.
Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Health Technology |
Leavey School of Business
Leavey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.